{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:33:07Z","timestamp":1786984387422,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.antiviral.2013.11.002","type":"journal-article","created":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T23:26:34Z","timestamp":1384989994000},"page":"82-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A 3Cpro-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents"],"prefix":"10.1016","volume":"101","author":[{"given":"Zhiwei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3595-5467","authenticated-orcid":false,"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.11.002_b0005","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1128\/JVI.02249-10","article-title":"Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity","volume":"85","author":"Arita","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0010","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1099\/vir.0.2008\/002915-0","article-title":"Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity","volume":"89","author":"Arita","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0015","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1099\/vir.0.012096-0","article-title":"Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime","volume":"90","author":"Arita","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0020","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1245\/s10434-012-2313-7","article-title":"Bioluminescence imaging serves as a dynamic marker for guiding and assessing thermal treatment of cancer in a preclinical model","volume":"19","author":"Au","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2013.11.002_b0030","doi-asserted-by":"crossref","first-page":"956794","DOI":"10.1155\/2012\/956794","article-title":"Application of bioluminescence imaging for in vivo monitoring of fungal infections","volume":"2012","author":"Brock","year":"2012","journal-title":"Int. J. Microbiol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.vaccine.2011.11.087","article-title":"Selection and characterization of vaccine strain for enterovirus 71 vaccine development","volume":"30","author":"Chang","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2013.11.002_b0040","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1471-4159.2008.05226.x","article-title":"Inhibition of ATF-3 expression by B-Raf mediates the neuroprotective action of GW5074","volume":"105","author":"Chen","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.antiviral.2013.11.002_b0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1099\/vir.0.19423-0","article-title":"A murine oral enterovirus 71 infection model with central nervous system involvement","volume":"85","author":"Chen","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0050","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1471-4159.2004.02530.x","article-title":"The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism","volume":"90","author":"Chin","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.antiviral.2013.11.002_b0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jmb.2011.03.007","article-title":"Crystal structure of human enterovirus 71 3C protease","volume":"408","author":"Cui","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1423-0127-19-73","article-title":"The highly conserved 5\u2019 untranslated region as an effective target towards the inhibition of enterovirus 71 replication by unmodified and appropriate 2\u2032-modified siRNAs","volume":"19","author":"Deng","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2013.11.002_b0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1462-5822.2004.00378.x","article-title":"In vivo bioluminescence imaging for integrated studies of infection","volume":"6","author":"Doyle","year":"2004","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0070","doi-asserted-by":"crossref","first-page":"e14043","DOI":"10.1371\/journal.pone.0014043","article-title":"Bioluminescence imaging allows monitoring hepatitis C virus core protein inhibitors in mice","volume":"5","author":"Du","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.11.002_b0075","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nmeth.1389","article-title":"A general life-death selection strategy for dissecting protein functions","volume":"6","author":"Ear","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.antiviral.2013.11.002_b0080","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/1087057111412183","article-title":"A high-throughput screening assay for the identification of flavivirus NS5 capping enzyme GTP-binding inhibitors: implications for antiviral drug development","volume":"16","author":"Geiss","year":"2011","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.antiviral.2013.11.002_b0085","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00969-13","article-title":"In vivo bioluminescent imaging of influenza A virus infection and characterization of novel cross-protective monoclonal antibodies","author":"Heaton","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0090","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.gt.3301983","article-title":"Progress and prospects: naked DNA gene transfer and therapy","volume":"10","author":"Herweijer","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.antiviral.2013.11.002_b0095","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cell.2010.03.050","article-title":"Viral reorganization of the secretory pathway generates distinct organelles for RNA replication","volume":"141","author":"Hsu","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2013.11.002_b0100","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.11.002_b0105","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1128\/JVI.01779-10","article-title":"Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model","volume":"85","author":"Khong","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/1045-1056(91)90039-M","article-title":"A simplified multiwell plate assay for the measurement of hepatitis A virus infectivity","volume":"19","author":"Krah","year":"1991","journal-title":"Biologicals"},{"key":"10.1016\/j.antiviral.2013.11.002_b0115","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/JVI.76.4.1649-1662.2002","article-title":"Novel design architecture for genetic stability of recombinant poliovirus: the manipulation of G\/C contents and their distribution patterns increases the genetic stability of inserts in a poliovirus-based RPS-Vax vector system","volume":"76","author":"Lee","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.virusres.2012.07.028","article-title":"Evidences for intertypic and intratypic recombinant events in EV71 of hand, foot and mouth disease during an epidemic in Hubei Province, China, 2011","volume":"169","author":"Li","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2013.11.002_b0125","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2012.03.010","article-title":"Safety and immunogenicity of a novel human enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial","volume":"30","author":"Li","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2013.11.002_b0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.virusres.2005.04.018","article-title":"Coxsackievirus B3 replication is related to activation of the late extracellular signal-regulated kinase (ERK) signal","volume":"113","author":"Lim","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2013.11.002_b0135","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.yjmcc.2005.02.018","article-title":"Long-term cardiac gene expression using a coxsackieviral vector","volume":"38","author":"Lim","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vaccine.2006.06.083","article-title":"High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture","volume":"25","author":"Liu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2013.11.002_b0145","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1128\/JVI.00787-11","article-title":"Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design","volume":"85","author":"Lu","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0150","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1128\/JVI.76.7.3365-3373.2002","article-title":"Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway","volume":"76","author":"Luo","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.suronc.2010.07.008","article-title":"Bioluminescence imaging correlates with tumor progression in an orthotopic mouse model of lung cancer","volume":"21","author":"Madero-Visbal","year":"2012","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0160","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1128\/JVI.62.12.4586-4593.1988","article-title":"Poliovirus proteinase 3C: large-scale expression, purification, and specific cleavage activity on natural and synthetic substrates in vitro","volume":"62","author":"Nicklin","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virusres.2012.06.025","article-title":"In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against enterovirus 71","volume":"169","author":"Pourianfar","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2013.11.002_b0170","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/ncomms2338","article-title":"In vivo imaging of virological synapses","volume":"3","author":"Sewald","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2013.11.002_b0175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.antiviral.2012.12.010","article-title":"Development and characterization of a stable eGFP enterovirus 71 for antiviral screening","volume":"97","author":"Shang","year":"2012","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.antiviral.2013.11.002_b0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.antiviral.2012.12.005","article-title":"Antiviral drug discovery for the treatment of enterovirus 71 infections","volume":"97","author":"Shang","year":"2012","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.antiviral.2013.11.002_b0185","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cbpa.2011.10.014","article-title":"Split-protein systems: beyond binary protein-protein interactions","volume":"15","author":"Shekhawat","year":"2011","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0190","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1128\/JVI.05063-11","article-title":"Host factors in enterovirus 71 replication","volume":"85","author":"Shih","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0195","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/156652311798192833","article-title":"Experimental and clinical application of plasmid DNA in the field of central nervous diseases","volume":"11","author":"Shimamura","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.antiviral.2013.11.002_b0200","series-title":"The Laboratory Mouse","article-title":"Routs of administration","author":"Shimizu","year":"2004"},{"key":"10.1016\/j.antiviral.2013.11.002_b0205","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/978-1-61779-415-5_30","article-title":"Bioluminescence imaging of bone metastasis in rodents","volume":"816","author":"Snoeks","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0210","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/sj.mt.6300287","article-title":"Inhibition of enterovirus 71 in virus-infected mice by RNA interference","volume":"15","author":"Tan","year":"2007","journal-title":"Mol. Ther."},{"issue":"346\u2013350","key":"10.1016\/j.antiviral.2013.11.002_b0215","first-page":"345","article-title":"Characterization of lacZ complementation deletions using membrane receptor dimerization","volume":"34","author":"Thormeyer","year":"2003","journal-title":"Biotechniques"},{"key":"10.1016\/j.antiviral.2013.11.002_b0220","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000321351","article-title":"Destabilization of coxsackievirus b3 genome integrated with enhanced green fluorescent protein gene","volume":"54","author":"Tong","year":"2011","journal-title":"Intervirology"},{"key":"10.1016\/j.antiviral.2013.11.002_b0225","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/cr.2012.129","article-title":"Coxsackievirus mutants that can bypass host factor PI4KIIIbeta and the need for high levels of PI4P lipids for replication","volume":"22","author":"van der Schaar","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2013.11.002_b0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2011.11.001","article-title":"MEK1-ERKs signal cascade is required for the replication of enterovirus 71 (EV71)","volume":"93","author":"Wang","year":"2012","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.antiviral.2013.11.002_b0235","doi-asserted-by":"crossref","first-page":"503165","DOI":"10.1155\/2012\/503165","article-title":"Antiviral Ability of Kalanchoe gracilis leaf extract against enterovirus 71 and coxsackievirus A16","volume":"2012","author":"Wang","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.antiviral.2013.11.002_b0240","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.antiviral.2010.04.010","article-title":"Bioluminescence imaging of hepatitis C virus NS3\/4A serine protease activity in cells and living animals","volume":"87","author":"Wang","year":"2010","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.antiviral.2013.11.002_b0245","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.antiviral.2011.12.004","article-title":"MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region","volume":"93","author":"Wang","year":"2012","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.antiviral.2013.11.002_b0250","doi-asserted-by":"crossref","first-page":"e1000593","DOI":"10.1371\/journal.ppat.1000593","article-title":"Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation","volume":"5","author":"Weng","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.11.002_b0255","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jviromet.2009.04.002","article-title":"Identification of small interfering RNAs which inhibit the replication of several enterovirus 71 strains in China","volume":"159","author":"Wu","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2013.11.002_b0260","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1089\/adt.2011.436","article-title":"Development of a cell-based high throughput luciferase enzyme fragment complementation assay to identify nuclear-factor-e2-related transcription factor 2 activators","volume":"10","author":"Xie","year":"2012","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0265","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1016\/j.vaccine.2010.03.003","article-title":"EV71: an emerging infectious disease vaccine target in the Far East?","volume":"28","author":"Xu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2013.11.002_b0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1743-422X-9-8","article-title":"Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications","volume":"9","author":"Xu","year":"2012","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2013.11.002_b0275","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/00365548.2011.634433","article-title":"Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16","volume":"44","author":"Yan","year":"2012","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.11.002_b0280","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.3390\/molecules170910370","article-title":"Antiviral effect of matrine against human enterovirus 71","volume":"17","author":"Yang","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.antiviral.2013.11.002_b0285","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.bmcl.2012.01.102","article-title":"Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo","volume":"22","author":"Yang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2013.11.002_b0290","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF02253368","article-title":"Neutralizing antibody provided protection against Enterovirus type 71 lethal challenge in neonatal mice","volume":"7","author":"Yu","year":"2000","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2013.11.002_b0295","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/infdis\/jir745","article-title":"Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis","volume":"205","author":"Yun","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.11.002_b0300","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00234-011-0979-3","article-title":"MRI and associated clinical characteristics of EV71-induced brainstem encephalitis in children with hand-foot-mouth disease","volume":"54","author":"Zeng","year":"2012","journal-title":"Neuroradiology"},{"key":"10.1016\/j.antiviral.2013.11.002_b0305","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jcv.2011.12.025","article-title":"Seroepidemiology of enterovirus 71 infection prior to the 2011 season in children in Shanghai","volume":"53","author":"Zeng","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2013.11.002_b0310","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.antiviral.2012.12.029","article-title":"Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model","volume":"97","author":"Zhang","year":"2013","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.antiviral.2013.11.002_b0315","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(12)61764-4","article-title":"Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213003240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213003240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T04:36:10Z","timestamp":1597034170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213003240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":63,"alternative-id":["S0166354213003240"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.11.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 3Cpro-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}